AnalystsKen TrbovichKen Trbovich's Stock Forecasts
AnalystsKen Trbovich
Sectors:
Analyst Ranking
Bottom 23%
#3770 out of 4871 analysts
Average Return
-14.53%
Win Rate
25%1 out of 4
Risk vs Reward
Poor
Good
Ken Trbovich's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Supernus Pharmaceuticals IncSUPN | +23.85% | $37.15 | $46.01 | 2017-12-04 - 2018-12-04 | Strong Buy |
Ken Trbovich Analyst Color
Get additional color on Ken Trbovich's coverage of popular stocks
Ken Trbovich's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Supernus Pharmaceuticals IncSUPN | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Pacira Biosciences IncPCRX | 3 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Tvardi Therapeutics IncTVRD | 2 | Hold | $252.00 | N/A | Downgrades | 8 years ago |
Acorda Therapeutics IncACORQ | 2 | Strong Buy | $4,560.00 | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.